EPH Receptor B2 (EPHB2) Peptid
EPHB2
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle EPH Receptor B2 (EPHB2) Produkte
- EPH Receptor B2 (EPHB2)
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-TPX2 antibody (Catalog #: ARP46176_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- EPH Receptor B2 (EPHB2)
- Hintergrund
-
TPX2 binding decreases the size and accessibility of a hydrophobic pocket, adjacent to the ATP site, to inhibitors.
Alias Symbols: C20orf1, C20orf2, DIL-2, DIL2, FLS353, GD:C20orf1, HCA519, HCTP4, REPP86, p100
Protein Interaction Partner: AURKA,HMMR,TPX2,AURKA
Protein Size: 747 - Molekulargewicht
- 86 kDa
- Gen-ID
- 22974
- NCBI Accession
- NM_012112, NP_036244
- UniProt
- Q9ULW0
-
Sie sind hier:
